Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Xconomy: Poseida To Advance Car-t For Myeloma With Novartis-led $142M Round
LPNEWS

Xconomy: Poseida To Advance Car-t For Myeloma With Novartis-led $142M Round

by xconomy.com posted 4months ago 24 views
The race to bring CAR-T cell therapy to multiple myeloma, a persistent and deadly cancer of the bone marrow, continued on Monday with a fresh round of funding for Poseida Therapeutics. Swiss pharma giant Novartis has invested $75 million in a $142 million Series C round for San Diego-based Poseida, which is one of several […]

In this article